GlassScriptPhysician profile
Hamdallah Ashkar
NPI 1659834588
$1,363.97
in general payments reported to CMS, 2019-2025
12 companies · $762 in 2025
The $762 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $203 · 2024: $398 · 2025: $762.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740 · Education: $624.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.10 |
| Education | $623.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $523.88 | 2024-2025 | Ensite |
| Abiomed | $262.81 | 2024-2025 | Impella |
| Stryker Corporation | $124.77 | 2025 | Flowtriever, Artix Mt |
| Astrazeneca Pharmaceuticals LP | $99.99 | 2023 | Brilinta |
| Boston Scientific Corporation | $79.22 | 2025 | General - Therapies, General - Brady |
| Pfizer INC. | $53.00 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $52.91 | 2023 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $48.16 | 2024-2025 | |
| Inari Medical, INC. | $47.69 | 2024-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Impulse Dynamics (USA) INC. | $33.18 | 2023 | Optimizer |
| Penumbra, INC. | $19.99 | 2024 | Indigo System |
| Atricure, INC. | $18.37 | 2025 | Atriclip Laa Exclusion System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamdallah Ashkar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.